IP Library Granted Patent US 8,465,539
Granted Patent B2
US 8,465,539 · App. 13/047,226 · Granted Jun 18, 2013

Device viewable under an imaging beam

Inventor: Kieran Murphy (Baltimore, MD)
Assignee: Kieran Murphy, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,465,539
App. No.
13/047,226
Granted
Jun 18, 2013
Kind
B2
Abstract

The invention provides a stent made from a material operable to perform a stent's desired therapeutic functions, and also made from a material that has a radiopacity that substantially preserves the appearance of the stent when the stent is viewed under a CT imaging beam. Such a stent can allow for follow-up of the stent and the surrounding blood-vessel on CT.

Claims (13)

1. A stent, comprising:

a material having structure to provide three-dimensional visualization of a surrounding tissue when said stent is inserted into said tissue and viewed under an imaging beam,

said stent having:

a single coating layer selected from a group consisting of: a hydrophilic polymer, a hydrophobic polymer, and a fatty acid polymer;

a density enhancing radiologic opacifier embedded into said single coating layer, said single coating layer and said embedded opacifier material together providing a first Hounsfield image density suitable for viewing under a first image modality used during device insertion into a patient, wherein said density enhancing radiologic opacifier material is configured to elute from said single coating layer so as to provide a second Hounsfield image density suitable for viewing under a second image modality used for subsequent visualization of surrounding tissue, and wherein the second Hounsfield image density is less than about 1200 Hounsfield Units; and

a restenosis inhibiting drug embedded into said single coating layer.

2. The stent of claim 1 , wherein residual radiographic density measurements of said stent provide a measure of said restenosis inhibiting drug still retained within said polymer.

3. The stent of claim 1 , wherein said stent is configured to elute said density enhancing radiologic opacifier material by bulk erosion.

4. The stent of claim 1 , wherein said stent is configured to elute said density enhancing radiologic opacifier material by surface erosion.

5. The stent of claim 1 , wherein said stent is configured to elute said density enhancing radiologic opacifier material by diffusion.

6. The stent of claim 1 , wherein said stent is configured to elute said density enhancing radiologic opacifier material by degradation.

7. The stent of claim 1 , wherein said imaging comprises CT.

8. The stent of claim 1 , wherein said imaging comprises MR.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2015
From: MURPHY, KIERAN P.
To: KIERAN MURPHY LLC
Reel/Frame 036573/0181 →
Continuity (5)
Division 10727667 · Dec 5, 2003
Continuation In Part 10394007 · Mar 24, 2003
Provisional Application 60366530 · Mar 25, 2002
Provisional Application 60366529 · Mar 25, 2002
Related Publication 20110166645A1 · Jul 7, 2011